{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:01:45Z","timestamp":1793314905808,"version":"4.5.0"},"reference-count":124,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Obstetric antiphospholipid syndrome (OAPS) is a complex autoimmune disorder that significantly compromises pregnancy, manifesting as recurrent miscarriage, stillbirth, placental insufficiency, and preeclampsia. Its increasing prevalence underscores the pressing need to elucidate its multifaceted pathogenic mechanisms to improve maternal and fetal outcomes. While traditionally attributed to thrombosis driven by antiphospholipid antibodies (aPL), emerging evidence indicates that OAPS can disrupt placental perfusion, impair trophoblast proliferation and invasion, and compromise placental angiogenesis even in the absence of overt thrombotic events. Beyond direct effects on trophoblasts and vascular remodeling, aPLs profoundly perturb the immune milieu at the maternal\u2013fetal interface, encompassing complement activation, excessive formation of neutrophil extracellular traps (NETs), dysfunction of decidual natural killer cells and macrophages, and dysregulated B cell responses. These immune-mediated alterations collectively establish a sustained pro-inflammatory environment that undermines placental development and predisposes to adverse pregnancy outcomes. This review provides a comprehensive synthesis of the immunopathogenic mechanisms of OAPS that extend beyond thrombosis, and emphasizes the intricate crosstalk between immune cells and the complement-NET axis. A deeper understanding of these immune-mediated pathways may inform the development of targeted therapeutic strategies to optimize maternal and fetal outcomes in affected pregnancies.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1722080","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T06:33:44Z","timestamp":1764138824000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Immune-mediated mechanisms and maternal-fetal interface dysfunction in obstetric antiphospholipid syndrome"],"prefix":"10.3389","volume":"16","author":[{"given":"Guangyu","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinbiao","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lang","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e069717","DOI":"10.1136\/bmj-2021-069717","article-title":"Antiphospholipid syndrome: advances in diagnosis, pathogenesis, and management","volume":"380","author":"Knight","year":"2023","journal-title":"BMJ"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60709-X","article-title":"Antiphospholipid syndrome","volume":"376","author":"Ruiz-Irastorza","year":"2010","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","first-page":"17104","DOI":"10.1038\/nrdp.2017.104","article-title":"Antiphospholipid syndrome","volume":"4","author":"Schreiber","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2018.03.018","article-title":"Antiphospholipid syndrome: An update on risk factors for pregnancy outcome","volume":"17","author":"De Carolis","year":"2018","journal-title":"Autoimmun Rev"},{"key":"B5","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1001\/archinte.164.1.77","article-title":"High impact of antiphospholipid syndrome on irreversible organ damage and survival of patients with systemic lupus erythematosus","volume":"164","author":"Ruiz-Irastorza","year":"2004","journal-title":"Arch Intern Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2018.12.006","article-title":"The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): A survey of 1000 consecutive cases","volume":"18","author":"Alijotas-Reig","year":"2019","journal-title":"Autoimmun Rev"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/art.10187","article-title":"Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients","volume":"46","author":"Cervera","year":"2002","journal-title":"Arthritis Rheum"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1177\/0961203312458839","article-title":"C6 knock-out mice are protected from thrombophilia mediated by antiphospholipid antibodies","volume":"21","author":"Carrera-Mar\u00edn","year":"2012","journal-title":"Lupus"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-08-522623","article-title":"Comparative incidence of pregnancy outcomes in treated obstetric antiphospholipid syndrome: the NOH-APS observational study","volume":"123","author":"Bouvier","year":"2014","journal-title":"Blood"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.080763","article-title":"Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial","volume":"36","author":"Laskin","year":"2009","journal-title":"J Rheumatol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1177\/0961203312465782","article-title":"Treatment of refractory obstetric antiphospholipid syndrome: the state of the art and new trends in the therapeutic management","volume":"22","author":"Alijotas-Reig","year":"2013","journal-title":"Lupus"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2015.01.008","article-title":"Histopathology in the placentae of women with antiphospholipid antibodies: A systematic review of the literature","volume":"14","author":"Ca","year":"2015","journal-title":"Autoimmun Rev"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1042\/bst0280202","article-title":"Structure-function relations in the human placenta","volume":"28","author":"Dockery","year":"2000","journal-title":"Biochem Soc Trans"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1159\/000300969","article-title":"Fine structure of the human placenta in prolonged pregnancy","volume":"9","author":"Thliveris","year":"1978","journal-title":"Preliminary Rep Gynecol Obstet Invest"},{"key":"B15","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s004180050311","article-title":"Villous cytotrophoblast regulation of the syncytial apoptotic cascade in the human placenta","volume":"110","author":"Huppertz","year":"1998","journal-title":"Histochem Cell Biol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1053\/plac.1999.0399","article-title":"Proliferation, differentiation and apoptosis in villous trophoblast at 13\u201341 weeks of gestation (including observations on annulate lamellae and nuclear pore complexes)","volume":"20","author":"Mayhew","year":"1999","journal-title":"Placenta"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.placenta.2011.07.081","article-title":"Trophoblast deportation part I: review of the evidence demonstrating trophoblast shedding and deportation during human pregnancy","volume":"32","author":"Askelund","year":"2011","journal-title":"Placenta"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.placenta.2011.06.019","article-title":"Trophoblast deportation part II: a review of the maternal consequences of trophoblast deportation","volume":"32","author":"Pantham","year":"2011","journal-title":"Placenta"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2021.01.012","article-title":"Molecular and immunological developments in placentas","volume":"82","author":"Nakashima","year":"2021","journal-title":"Hum Immunol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e13433","DOI":"10.1111\/aji.13433","article-title":"Uterine natural killer cells and recurrent spontaneous abortion","volume":"86","author":"Fu","year":"2021","journal-title":"Am J Reprod Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2024.12.032","article-title":"The maternal-fetal interface at single-cell resolution: uncovering the cellular anatomy of the placenta and decidua","volume":"232","author":"Levenson","year":"2025","journal-title":"Am J Obstet Gynecol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jri.2020.103264","article-title":"Functional regulation of decidual macrophages during pregnancy","volume":"143","author":"Sun","year":"2021","journal-title":"J Reprod Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deh378","article-title":"An increase in the absolute count of CD56dimCD16+CD69+ NK cells in the peripheral blood is associated with a poorer IVF treatment and pregnancy outcome","volume":"19","author":"Thum","year":"2004","journal-title":"Hum Reprod"},{"key":"B24","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1093\/humupd\/dmu049","article-title":"Antiphospholipid antibodies and the placenta: a systematic review of their in vitro effects and modulation by treatment","volume":"21","author":"Tong","year":"2015","journal-title":"Hum Reprod Update"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1002\/art.40136","article-title":"Antiphospholipid syndrome and pregnancy: pathogenesis to translation","volume":"69","author":"Abrahams","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11030675","article-title":"Pathogenesis, diagnosis and management of obstetric antiphospholipid syndrome: A comprehensive review","volume":"11","author":"Alijotas-Reig","year":"2022","journal-title":"J Clin Med"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.placenta.2005.01.010","article-title":"Determination of non-bilayer phospholipid arrangements and their antibodies in placentae and sera of patients with hypertensive disorders of pregnancy","volume":"27","author":"Campos","year":"2006","journal-title":"Placenta"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(95)90502-2","article-title":"Monoclonal antiphosphatidylserine antibody reactivity against human first-trimester placental trophoblasts","volume":"172","author":"Katsuragawa","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0165-0378(92)90002-l","article-title":"Monoclonal antiphospholipid antibody reactivity against human placental trophoblast","volume":"22","author":"Lyden","year":"1992","journal-title":"J Reprod Immunol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)63479-7","article-title":"Human monoclonal antiphospholipid antibodies disrupt the annexin A5 anticoagulant crystal shield on phospholipid bilayers: evidence from atomic force microscopy and functional assay","volume":"163","author":"Rand","year":"2003","journal-title":"Am J Pathol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)83133-7","article-title":"Phospholipid binding properties of human placental anticoagulant protein-I, a member of the lipocortin family","volume":"264","author":"Tait","year":"1989","journal-title":"J Biol Chem"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-04-213520","article-title":"Hydroxychloroquine protects the annexin A5 anticoagulant shield from disruption by antiphospholipid antibodies: evidence for a novel effect for an old antimalarial drug","volume":"115","author":"Rand","year":"2010","journal-title":"Blood"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9378(97)70294-1","article-title":"Antiphospholipid immunoglobulin G antibodies reduce annexin-V levels on syncytiotrophoblast apical membranes and in culture media of placental villi","volume":"177","author":"Rand","year":"1997","journal-title":"Am J Obstet Gynecol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199707173370303","article-title":"Pregnancy loss in the antiphospholipid-antibody syndrome\u2013a possible thrombogenic mechanism","volume":"337","author":"Rand","year":"1997","journal-title":"N Engl J Med"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(94)90403-0","article-title":"Reduction of annexin-V (placental anticoagulant protein-I) on placental villi of women with antiphospholipid antibodies and recurrent spontaneous abortion","volume":"171","author":"Rand","year":"1994","journal-title":"Am J Obstet Gynecol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9378(97)70302-8","article-title":"Antiphosphatidylserine antibody removes annexin-V and facilitates the binding of prothrombin at the surface of a choriocarcinoma model of trophoblast differentiation","volume":"177","author":"Vogt","year":"1997","journal-title":"Am J Obstet Gynecol"},{"key":"B37","article-title":"Pathology of the placenta","volume":"7","author":"Fox","year":"1978","journal-title":"Major Probl Pathol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1111\/aji.12114","article-title":"Management of women with recurrent pregnancy losses and antiphospholipid antibody syndrome","volume":"69","author":"Kwak-Kim","year":"2013","journal-title":"Am J Reprod Immunol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"e13185","DOI":"10.1111\/aji.13185","article-title":"Complement activation in the plasma and placentas of women with different subsets of antiphospholipid syndrome","volume":"82","author":"Scambi","year":"2019","journal-title":"Am J Reprod Immunol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1002\/path.2893","article-title":"Classical complement activation as a footprint for murine and human antiphospholipid antibody-induced fetal loss","volume":"225","author":"Cohen","year":"2011","journal-title":"J Pathol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2006.10.879","article-title":"Excessive complement activation is associated with placental injury in patients with antiphospholipid antibodies","volume":"196","author":"Shamonki","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1177\/0961203312444172","article-title":"Complementemia and obstetric outcome in pregnancy with antiphospholipid syndrome","volume":"21","author":"De Carolis","year":"2012","journal-title":"Lupus"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kes225","article-title":"Primary anti-phospholipid syndrome: any role for serum complement levels in predicting pregnancy complications","volume":"51","author":"Reggia","year":"2012","journal-title":"Rheumatol (Oxford)"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1172\/JCI18817","article-title":"Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome","volume":"112","author":"Girardi","year":"2003","journal-title":"J Clin Invest"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1159\/000075690","article-title":"The role of complement in the antiphospholipid syndrome","volume":"7","author":"Salmon","year":"2004","journal-title":"Curr Dir Autoimmun"},{"key":"B46","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.molimm.2004.07.043","article-title":"A novel inhibitor of the alternative complement pathway prevents antiphospholipid antibody-induced pregnancy loss in mice","volume":"42","author":"Thurman","year":"2005","journal-title":"Mol Immunol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-009-8183-5","article-title":"Complement activation and pregnancy failure","volume":"39","author":"Tincani","year":"2010","journal-title":"Clin Rev Allergy Immunol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/275699a0","article-title":"The biochemistry of complement","volume":"275","author":"Porter","year":"1978","journal-title":"Nature"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00449","article-title":"Complement in the pathophysiology of the antiphospholipid syndrome","volume":"10","author":"Chaturvedi","year":"2019","journal-title":"Front Immunol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01388","article-title":"Pathogenic role of complement in antiphospholipid syndrome and therapeutic implications","volume":"9","author":"Tedesco","year":"2018","journal-title":"Front Immunol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/imr.13130","article-title":"Initiation of the alternative pathway of complement and the history of \u201ctickover","volume":"313","author":"Pangburn","year":"2023","journal-title":"Immunol Rev"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1160\/TH11-08-0554","article-title":"Complement activation in patients with isolated antiphospholipid antibodies or primary antiphospholipid syndrome","volume":"107","author":"Breen","year":"2012","journal-title":"Thromb Haemost"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1084\/jem.200116116","article-title":"Complement C3 activation is required for antiphospholipid antibody-induced fetal loss","volume":"195","author":"Holers","year":"2002","journal-title":"J Exp Med"},{"key":"B54","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1080\/25785826.2021.1969116","article-title":"Obstetric anti-phospholipid syndrome: from pathogenesis to treatment","volume":"45","author":"Kaneko","year":"2022","journal-title":"Immunol Med"},{"key":"B55","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/nrneph.2017.156","article-title":"The renaissance of complement therapeutics","volume":"14","author":"Ricklin","year":"2018","journal-title":"Nat Rev Nephrol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.2000.01305.x","article-title":"Cytokine-mediated up-regulation of CD55 and CD59 protects human hepatoma cells from complement attack","volume":"121","author":"Spiller","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.168.12.6298","article-title":"Role of membrane cofactor protein (CD46) in regulation of C4b and C3b deposited on cells","volume":"168","author":"Barilla-LaBarca","year":"2002","journal-title":"J Immunol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2011.04400.x","article-title":"CD46 in innate and adaptive immunity: an update","volume":"164","author":"Cardone","year":"2011","journal-title":"Clin Exp Immunol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.178.1.352","article-title":"Decay-accelerating factor must bind both components of the complement alternative pathway C3 convertase to mediate efficient decay","volume":"178","author":"Harris","year":"2007","journal-title":"J Immunol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M611650200","article-title":"Structure-based mapping of DAF active site residues that accelerate the decay of C3 convertases","volume":"282","author":"Kuttner-Kondo","year":"2007","journal-title":"J Biol Chem"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1111\/cei.13313","article-title":"Mitigating placental injuries through up-regulating DAF in experimental APS mice: new mechanism of progesterone","volume":"197","author":"Zhang","year":"2019","journal-title":"Clin Exp Immunol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.5603\/19758","article-title":"Complement inhibitory proteins expression in placentas of thrombophilic women","volume":"50","author":"Wirstlein","year":"2012","journal-title":"Folia Histochem Cytobiol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4294","article-title":"An emerging role for neutrophil extracellular traps in noninfectious disease","volume":"23","author":"Jorch","year":"2017","journal-title":"Nat Med"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204837","article-title":"Neutrophil extracellular traps induce endothelial dysfunction in systemic lupus erythematosus through the activation of matrix metalloproteinase-2","volume":"74","author":"Carmona-Rivera","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0909927107","article-title":"Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis","volume":"107","author":"Hakkim","year":"2010","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.15321","article-title":"Antiphospholipid antibody-activated NETs exacerbate trophoblast and endothelial cell injury in obstetric antiphospholipid syndrome","volume":"24","author":"Lu","year":"2020","journal-title":"J Cell Mol Med"},{"key":"B67","doi-asserted-by":"publisher","first-page":"2990","DOI":"10.1002\/art.39247","article-title":"Release of neutrophil extracellular traps by neutrophils stimulated with antiphospholipid antibodies: a newly identified mechanism of thrombosis in the antiphospholipid syndrome","volume":"67","author":"Yalavarthi","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"eabj7465","DOI":"10.1126\/scitranslmed.abj7465","article-title":"A targetable pathway in neutrophils mitigates both arterial and venous thrombosis","volume":"14","author":"Nayak","year":"2022","journal-title":"Sci Transl Med"},{"key":"B69","doi-asserted-by":"publisher","first-page":"e0218946","DOI":"10.1371\/journal.pone.0218946","article-title":"Neutrophil extracellular traps (NET) induced by different stimuli: A comparative proteomic analysis","volume":"14","author":"Petretto","year":"2019","journal-title":"PloS One"},{"key":"B70","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41423-018-0024-0","article-title":"NETosis, complement, and coagulation: a triangular relationship","volume":"16","author":"De Bont","year":"2019","journal-title":"Cell Mol Immunol"},{"key":"B71","first-page":"66","article-title":"Degradation of neutrophil extracellular traps is decreased in patients with antiphospholipid syndrome","volume":"32","author":"Leffler","year":"2014","journal-title":"Clin Exp Rheumatol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1002\/art.41460","article-title":"Anti\u2013neutrophil extracellular trap antibodies and impaired neutrophil extracellular trap degradation in antiphospholipid syndrome","volume":"72","author":"Zuo","year":"2020","journal-title":"Arthritis Rheumatol."},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-022-00787-0","article-title":"Neutrophil extracellular traps in systemic autoimmune and autoinflammatory diseases","volume":"23","author":"Wigerblad","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.910908","article-title":"Impact of neutrophil extracellular traps on thrombosis formation: new findings and future perspective","volume":"12","author":"Zhou","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"e32366","DOI":"10.1371\/journal.pone.0032366","article-title":"Neutrophil extracellular traps directly induce epithelial and endothelial cell death: a predominant role of histones","volume":"7","author":"Saffarzadeh","year":"2012","journal-title":"PloS One"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-06-722298","article-title":"In vitro activation of coagulation by human neutrophil DNA and histone proteins but not neutrophil extracellular traps","volume":"129","author":"Noubouossie","year":"2017","journal-title":"Blood"},{"key":"B77","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/s41392-024-01933-x","article-title":"Neutrophil extracellular traps in homeostasis and disease","volume":"9","author":"Wang","year":"2024","journal-title":"Sig Transduct Target Ther"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2015.10.012","article-title":"Extracellular histones induce tissue factor expression in vascular endothelial cells via TLR and activation of NF-\u03baB and AP-1","volume":"137","author":"Yang","year":"2016","journal-title":"Thromb Res"},{"key":"B79","doi-asserted-by":"publisher","first-page":"150909","DOI":"10.1016\/j.tmrv.2025.150909","article-title":"Analytical review: neutrophil extracellular traps and antiphospholipid syndrome","author":"Butt","year":"2025","journal-title":"Transfus Med Rev"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab853","article-title":"A new pro-thrombotic mechanism of neutrophil extracellular traps in antiphospholipid syndrome: impact on activated protein C resistance","volume":"61","author":"Foret","year":"2022","journal-title":"Rheumatol (Oxford)"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2023.109745","article-title":"The pathogenesis of obstetric APS: a 2023 update","volume":"255","author":"Mineo","year":"2023","journal-title":"Clin Immunol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2025.04.038","article-title":"Neutrophil extracellular traps aggravate placental injury in OAPS by facilitating activation of BNIP3 mediated mitophagy","volume":"235","author":"Wang","year":"2025","journal-title":"Free Radic Biol Med"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.34172\/ipp.2024.40644","article-title":"The association of matrix metalloproteinase-9 and fetal fibronectin in the first trimester threatened miscarriage","volume":"10","author":"Maki","year":"2024","journal-title":"Immunopathol Persa"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1102404","article-title":"Neutrophil extracellular traps that are not degraded in systemic lupus erythematosus activate complement exacerbating the disease","volume":"188","author":"Leffler","year":"2012","journal-title":"J Immunol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1111\/cei.12654","article-title":"Neutrophil extracellular traps can activate alternative complement pathways","volume":"181","author":"Wang","year":"2015","journal-title":"Clin Exp Immunol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00137","article-title":"NETosing neutrophils activate complement both on their own NETs and bacteria via alternative and non-alternative pathways","volume":"7","author":"Yuen","year":"2016","journal-title":"Front Immunol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1159\/000356980","article-title":"Myeloperoxidase directs properdin-mediated complement activation","volume":"6","author":"O\u2019Flynn","year":"2014","journal-title":"J Innate Immun"},{"key":"B88","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.molimm.2016.02.011","article-title":"Complement factor H modulates the activation of human neutrophil granulocytes and the generation of neutrophil extracellular traps","volume":"72","author":"Schneider","year":"2016","journal-title":"Mol Immunol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12959-022-00384-0","article-title":"Complement C5a induces the generation of neutrophil extracellular traps by inhibiting mitochondrial STAT3 to promote the development of arterial thrombosis","volume":"20","author":"Chen","year":"2022","journal-title":"Thromb J"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1002\/art.39239","article-title":"Promotion of hypercoagulability in antineutrophil cytoplasmic antibody-associated vasculitis by C5a-induced tissue factor-expressing microparticles and neutrophil extracellular traps","volume":"67","author":"Huang","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1076167","article-title":"Beta 2 glycoprotein I and neutrophil extracellular traps: Potential bridge between innate and adaptive immunity in anti-phospholipid syndrome","volume":"13","author":"Grossi","year":"2023","journal-title":"Front Immunol"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1456171","article-title":"B cells: roles in physiology and pathology of pregnancy","volume":"15","author":"Liu","year":"2024","journal-title":"Front Immunol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1111\/jth.14427","article-title":"Circulating plasmablasts contribute to antiphospholipid antibody production, associated with type I interferon upregulation","volume":"17","author":"Hisada","year":"2019","journal-title":"J Thromb Haemost"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1097\/CM9.0000000000000948","article-title":"Change of serum B-cell activating factor level in patients with positive antiphospholipid antibodies and previous adverse pregnancy outcomes and its significance","volume":"133","author":"Li","year":"2020","journal-title":"Chin Med J (Engl)"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1038\/srep20651","article-title":"A pathogenic IFN\u03b1, BLyS and IL-17 axis in Systemic Lupus Erythematosus patients","volume":"6","author":"L\u00f3pez","year":"2016","journal-title":"Sci Rep"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kev420","article-title":"Exploring BAFF: its expression, receptors and contribution to the immunopathogenesis of Sj\u00f6gren\u2019s syndrome","volume":"55","author":"Thompson","year":"2016","journal-title":"Rheumatol (Oxford)"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-12-017319","article-title":"A role for BLyS in the activation of innate immune cells","volume":"108","author":"Chang","year":"2006","journal-title":"Blood"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2018.01840","article-title":"Mechanisms of endothelial dysfunction in antiphospholipid syndrome: association with clinical manifestations","volume":"9","author":"Vel\u00e1squez","year":"2018","journal-title":"Front Physiol"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1038\/nri3795","article-title":"The generation of antibody-secreting plasma cells","volume":"15","author":"Nutt","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"B100","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12967-020-02289-w","article-title":"Transitional B cells involved in autoimmunity and their impact on neuroimmunological diseases","volume":"18","author":"Zhou","year":"2020","journal-title":"J Transl Med"},{"key":"B101","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s10238-021-00720-0","article-title":"Imbalance of circulating CTLA4+ follicular helper and follicular regulatory T cells in obstetric antiphospholipid syndrome","volume":"22","author":"Zhang","year":"2022","journal-title":"Clin Exp Med"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-08-593624","article-title":"\u03b22-Glycoprotein I\/HLA class II complexes are novel autoantigens in antiphospholipid syndrome","volume":"125","author":"Tanimura","year":"2015","journal-title":"Blood"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab416","article-title":"Characteristics of purified anti-\u03b22GPI IgG N-glycosylation associate with thrombotic, obstetric and catastrophic antiphospholipid syndrome","volume":"61","author":"Liu","year":"2022","journal-title":"Rheumatol (Oxford)"},{"key":"B104","doi-asserted-by":"publisher","first-page":"e13366","DOI":"10.1111\/sji.13366","article-title":"Changes in serum immunoglobulin G glycosylation patterns for antiphospholipid syndrome patients with lectin microarray","volume":"99","author":"Wang","year":"2024","journal-title":"Scand J Immunol"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1016\/j.jri.2016.09.002","article-title":"The role of decidual NK cells in pregnancies with impaired vascular remodelling","volume":"119","author":"Cartwright","year":"2017","journal-title":"J Reprod Immunol"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.689019","article-title":"The immune atlas of human deciduas with unexplained recurrent pregnancy loss","volume":"12","author":"Chen","year":"2021","journal-title":"Front Immunol"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1038\/s41421-020-00236-z","article-title":"Single-cell profiling of the human decidual immune microenvironment in patients with recurrent pregnancy loss","volume":"7","author":"Guo","year":"2021","journal-title":"Cell Discov"},{"key":"B108","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12958-022-00980-9","article-title":"Polarization disorder of decidual NK cells in unexplained recurrent spontaneous abortion revealed by single-cell transcriptome analysis","volume":"20","author":"Pan","year":"2022","journal-title":"Reprod Biol Endocrinol"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1016\/j.gpb.2020.11.002","article-title":"Single-cell immune landscape of human recurrent miscarriage","volume":"19","author":"Wang","year":"2021","journal-title":"Genomics Proteomics Bioinf"},{"key":"B110","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.jri.2014.06.002","article-title":"Popular myths in reproductive immunology","author":"Clark","year":"2014","journal-title":"J Reprod Immunol"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.663660","article-title":"Decidual natural killer cells: A good nanny at the maternal-fetal interface during early pregnancy","volume":"12","author":"Liu","year":"2021","journal-title":"Front Immunol"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1016\/j.jri.2022.103791","article-title":"Antiphospholipid antibody-mediated NK cell cytotoxicity","volume":"155","author":"Manukyan","year":"2023","journal-title":"J Reprod Immunol"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1080\/08820139.2020.1835949","article-title":"Increased peripheral NKG2A-NKG2D+CD3-CD16+CD56dim NK cell subset was positively correlated with antiphospholipid antibodies in patients of obstetric antiphospholipid syndrome","volume":"51","author":"Zhang","year":"2022","journal-title":"Immunol Invest"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1002\/art.22802","article-title":"Anti-beta2-glycoprotein I antibodies induce monocyte release of tumor necrosis factor alpha and tissue factor by signal transduction pathways involving lipid rafts","volume":"56","author":"Sorice","year":"2007","journal-title":"Arthritis Rheum"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2023-224930","article-title":"Single-cell transcriptome analyses reveal disturbed decidual homoeostasis in obstetric antiphospholipid syndrome","volume":"83","author":"Lu","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"B116","doi-asserted-by":"publisher","first-page":"e03480","DOI":"10.1002\/advs.202503480","article-title":"Deciphering the role and mechanism of decidual monocyte-derived macrophage infiltration in obstetric antiphospholipid syndrome at single-cell resolution","volume":"12","author":"Gao","year":"2025","journal-title":"Adv Sci (Weinh)"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1002\/art.34440","article-title":"Brief report: induction of sustained remission in recurrent catastrophic antiphospholipid syndrome via inhibition of terminal complement with eculizumab","volume":"64","author":"Shapira","year":"2012","journal-title":"Arthritis Rheum"},{"key":"B118","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4274\/tjh.2015.0197","article-title":"The role of complement inhibition in thrombotic angiopathies and antiphospholipid syndrome","volume":"33","author":"Erkan","year":"2016","journal-title":"Turk J Haematol"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.5BT0615-234R","article-title":"At the Bedside: Neutrophil extracellular traps (NETs) as targets for biomarkers and therapies in autoimmune diseases","volume":"99","author":"Barnado","year":"2016","journal-title":"J Leukoc Biol"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2016.00097","article-title":"The NET outcome\u201d: are neutrophil extracellular traps of any relevance to the pathophysiology of autoimmune disorders in childhood","volume":"4","author":"Giaglis","year":"2016","journal-title":"Front Pediatr"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1177\/0961203316682102","article-title":"Belimumab in primary antiphospholipid syndrome","volume":"26","author":"Yazici","year":"2017","journal-title":"Lupus"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102594","article-title":"Belimumab reduces antiphospholipid antibodies in primary triple-positive antiphospholipid syndrome","volume":"19","author":"Klemm","year":"2020","journal-title":"Autoimmun Rev"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2013.05.004","article-title":"Catastrophic Antiphospholipid Syndrome (CAPS) Registry Project Group (European Forum on Antiphospholipid Antibodies). Rituximab use in the catastrophic antiphospholipid syndrome: descriptive analysis of the CAPS registry patients receiving rituximab","volume":"12","author":"Berman","year":"2013","journal-title":"Autoimmun Rev"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.55563\/clinexprheumatol\/cc5taf","article-title":"Rituximab for refractory manifestations of the antiphospholipid syndrome: a multicentre Israeli experience","volume":"39","author":"Agmon-Levin","year":"2021","journal-title":"Clin Exp Rheumatol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1722080\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T06:33:45Z","timestamp":1764138825000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1722080\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,26]]},"references-count":124,"alternative-id":["10.3389\/fimmu.2025.1722080"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1722080","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,26]]},"article-number":"1722080"}}